AbbVie | ABBV - Trade Creditors



AbbVie reported 2.94B in Trade Creditors for its fiscal quarter ending in December of 2024.


Trade Creditors Change Date
AbbVie 2.94B 2.66B Dec/2024
Abbott USD 4.31B 92M Jun/2025
ALKERMES USD 99.21M 39.37M Jun/2025
Amgen USD 18.03B 15.63B Jun/2025
AstraZeneca 23.99B 1.44B Jun/2025
Biogen USD 408.4M 16.9M Jun/2025
BioMarin Pharmaceutical 684.25M 390.5M Jun/2025
Bristol-Myers Squibb USD 5.43B 1.42B Jun/2025
Eisai JPY 82.98B 8.59B Jun/2025
Eli Lilly USD 4.08B 633.7M Jun/2025
Gilead Sciences USD 582M 155M Jun/2025
GlaxoSmithKline 14.82B 329M Jun/2025
J&J USD 9.54B 766M Mar/2025
Medtronic USD 2.45B 163M Apr/2025
Merck USD 4.04B 261M Jun/2025
Neurocrine Biosciences 104.6M 5.4M Jun/2025
Novartis USD 4.51B 245M Jun/2025
Pacira USD 30.12M 6.95M Jun/2025
Perrigo USD 489M 13.3M Jun/2025
Pfizer USD 5.17B 74M Jun/2025
Regeneron Pharmaceuticals USD 723.9M 18.4M Jun/2025
Roche Holding 4.35B 828M Dec/2024
Sanofi 7.08B 14.54B Jun/2025
UCB 750M 1.66B Dec/2024
Ultragenyx Pharmaceutical USD 34.24M 13.21M Jun/2025
United Therapeutics 432M 426M Jun/2025
Vertex Pharmaceuticals USD 3.71B 3.27B Jun/2025
Zoetis USD 508M 88M Jun/2025